Agnieszka Konkel

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 108 citations

Medicine, Neurology, Pharmacology +10

Clinical manifestations of intermediate allele carriers in Huntington disease

Esther Cubo, María A. Ramos-Arroyo, Saül Martínez‐Horta et al. · Neurology · 2016 · 54 citations

Life Sciences, Genetics, Neurology +13

The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson's disease

Jarosław Dulski, Michał Schinwelski, Agnieszka Konkel et al. · Parkinsonism & Related Disorders · 2019 · 42 citations

Medicine, Neurology, Neuroscience +14

Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia

Emilia J. Sitek, Anna Barczak, Klaudia Kluj-Kozłowska et al. · Neurologia i Neurochirurgia Polska · 2015 · 28 citations

Health Professions, Neurology, Aphasia +8

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) – A Polish family with novel SACS mutations

Magdalena Krygier, Agnieszka Konkel, Michał Schinwelski et al. · Neurologia i Neurochirurgia Polska · 2017 · 18 citations

Life Sciences, Genetics, Molecular Genetics +11